[Perioperative treatment of patients with varicose veins using calcium dobesilate].
Altogether 120 patients with medium to serious forms of varicositas were examined perioperatively after having been divided into 3 groups. Groups I and II were administered perioperatively a daily dosage of 1000 mg (2 x 1 capsule) of the preparation Doxium (Ebewe Arzneimittel GmbH, Unterach am Attersee) during 8 weeks - 2 weeks preoperatively and 6 weeks postoperatively. Group III was used for control purposes. The following was valued as parameter of comparison: kind and seriousness of perioperative trouble, alteration of peripheric oedemas, results of plethysmographic examinations as well as light-reflex-rheography examinations and the post-operative healing-process. Groups I and II (medication of Doxium) showed a significant (p less than 0.05) reduction of the peripheric oedemas already in the preoperative state and postoperatively, the patients had less trouble and a quicker healing-process was observed compared with group III.
Mühleder
J
J
Abteilung für Chirurgie, des a. ö. Krankenhauses Krems a. d. Donau.
Ohner
W
W
Duma
S
S
D000328:Adult; D001557:Benzenesulfonates / Q000008:administration & dosage*; D002123:Calcium Dobesilate / Q000008:administration & dosage*; D002199:Capillary Permeability / Q000187:drug effects; D005260:Female; D006801:Humans; D008209:Lymphedema / Q000517:prevention & control; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D014648:Varicose Veins / Q000601:surgery*; D014945:Wound Healing / Q000187:drug effects
D001557:Benzenesulfonates; D002123:Calcium Dobesilate
Perioperative Behandlung von Varizenträgern mit Kalziumdobesilat.